The diagnostic value of pretreatment serum LDH in patients with limited disease small-cell lung carcinoma

International Journal of Biological Markers

Volumn 12, Issue 4, 1997, Pages 162-167

  Stokkel, M P M ^a   Van Eck Smit, B L F ^a   Zwinderman, A H ^a   Willems, L N A ^a   Pauwels, E K J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Lactate dehydrogenase; Limited disease; Occult metastases; Small cell lung cancer

Indexed keywords

LACTATE DEHYDROGENASE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LUNG CARCINOMA; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; REMISSION; RETROSPECTIVE STUDY; SURVIVAL RATE;

EID: 0031432011     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460089701200405     Document Type: Article

References (24)

1. Smith IE, Perren TJ, Ashley SA, et al. Carboplatin, etoposide and ifosfamide as intensive chemotherapy for small-cell lung cancer. J Clin Oncol 1990; 8: 899-905.
2. Elias AD. Dose-intensive therapy for small cell lung cancer. Chest 1995; 107: 261S-6S.
3. Feld R, Deboer G, Sagman U. Prognostic factors for small cell carcinoma of the lung. Eur J Cancer Clin Oncol 1988; 24: 353-5.
4. Dearing MP, Steinberg SM, Phelps R, et al. Outcome of patients with small-cell lung cancer: effect of changes in staging procedures and imaging technology on prognostic factors over 14 years. J Clin Oncol 1990; 8: 1042-9.
5. Healy EA, Abner A. Thoracic and cranial radiotherapy for limited-stage small cell lung cancer. Chest 1995; 107: 249S-54S.
6. Albain KS, Crowley JJ, LeBlanc M, Livingston RB. Determinants of improved outcome in small-cell lung cancer: an analysis of the 2580-Patient Southwest Oncology Group data base. J Clin Oncol 1990; 8: 1563-74.
7. Lassen U, Oesterlind K, Hansen M, Dombernowsky P, Bergman B, Hansen HH. Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years- an analysis of 1714 consecutive patients. J Clin Oncol 1995; 13: 1215-20.
8. McCracken JD, Janaki LM, Crowley JJ, et al. Concurrent chemotherapy/radiotherapy for limited small-cell lung carcinoma: a Southwest Oncology Group Study. J Clin Oncol 1990; 8: 892-8.
9. Spiegelman D, Maurer LH, Ware JH, et al. Prognostic factors in small-cell carcinoma of the lung: an analysis of 1521 patients. J Clin Oncol 1989; 7: 344-54.
10. Minna JD, Higgins GA, Glatstein EI. Cancer of the lung. In: De Vita VT, Hellman S, Rosenberg SA, eds. Cancer, principles and practice of oncology. Philadelphia, PA: Lippincott 1985; 507-98.
11. Troell RJ, Terris DJ. Detection of metastases from head and neck cancers. Laryngoscope 1995; 105: 247-50.
12. Beck PR, Belfield A, Spoomer RJ, Blumgart LH, Wood GB. Serum enzymes in colorectal cancer. Cancer 1979; 43: 1772-6.
13. Sagman U, Feld R, Evans WK, et al. The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancer. J Clin Oncol 1991; 9: 954-61.
14. Vezzoni MA, Lucchini R, Giardini R, et al. Lactate dehydrogenase levels in cellular extracts of human malignant lymphomas. Tumori 1983; 69: 279-82.
15. Sepherd FA, Ginsberg RJ, Haddad R, et al. Importance of clinical staging in limited small cell lung cancer: a valuable system to separate prognostic subgroups. J Clin Oncol 1993; 11: 1592-7.
16. Oesterlind K, Andersen PK. Prognostic factors in small cell lung cancer: multivariate model based on 778 patients treated with chemotherapy with or without irradiation. Cancer Res 1986; 46: 4189-94.
17. Cerney T, Blair V, Anderson H, Bramwell H, Thatcher N. Pretreatment prognostic factors and scoring system in 407 small cell lung cancer patients. Int J Cancer 1987; 39: 146-9.
18. Onoshi T, Hiraki S, Nakata Y, et al. Pretreatment serum albumin concentration and lactic dehydrogenase activity as prognostic factors in patients with small cell lung cancer. Acta Med Okayama 1982; 36: 487-90.
19. Vincent MD, Ashley SE, Smith IE. Prognostic factors in small cell lung cancer: a simple prognostic index is better than conventional staging. Eur J Cancer Clin Oncol 1987; 23: 1589-99.
20. Wang T, Feld R, Sagman U, et al. The combined use of LDH and CEA as independent prognostic markers for small cell lung cancer. Proc Am Assoc Cancer Res 1986; 27: 162.
21. Abrams J, Doyle LA, Aisner J. Staging, prognostic factors and special considerations in small cell lung cancer. Semin Oncol 1988; 15: 261-77.
22. Ihde DC, Makuch RQ, Carney DN, et al. Prognostic implications of stage of disease and sites of metastases in patients with small cell carcinoma of the lung treated with intensive combination chemotherapy. Am Rev Respir Dis 1981; 123: 500-7.
23. Sepherd FA, Evans WK, Feld R, et al. Adjuvant chemotherapy following surgical resection for small cell carcinoma of the lung. J Clin Oncol 1988; 6: 832-8.
24. Sagman U, Maki E, Evans WK, et al. Small-cell carcinoma of the lung: Derivation of a prognostic staging system. J Clin Oncol 1991; 9: 1639-49.